This is why tirzepatide tolerates higher functional dosing than semaglutide at equivalent weight-loss endpoints [5]
Initiation of treatment with tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist (GLP-1RA), early after a diagnosis of type 2 diabetes (T2D) may establish better and more durable glycemic control than current treatment approaches per guidelines and clinical practice, the authors said.
Youre in good hands
Weeks 25-48+: Continued progress beyond what dual agonists can achieve
This may include specific directions related to strength, quantity, dosage form, and use instructions
Nausea management strategies include eating smaller meals, avoiding high-fat foods around injection time, staying well-hydrated, and taking the injection at a time that positions peak nausea during sleep hours